Report Detail

Request for Sample of this report

Pharma & Healthcare Global Influenza Virus Vaccine (H1N1) Sales Market Report 2021

  • RnM3940380
    • |
  • 21 June, 2021
    • |
  • Global
    • |
  • 149 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

The global Influenza Virus Vaccine (H1N1) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Virus Vaccine (H1N1) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Intramuscular Vaccine
Nasal Spray Vaccine

Segment by Application
3 To 10 Years Old
10 To 18 Years Old
Above 18 Years Old
Other

The Influenza Virus Vaccine (H1N1) market is analysed and market size information is provided by regions (countries). Segment by Application, the Influenza Virus Vaccine (H1N1) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
CSL
NVS(Novartis)
Sanofi Pasteur
Medimmune
GSK
Baxter
Beijing Kexing Bio-Vaccine
Hualan Bio-Vaccine
Changchun Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Jiangsu Yanshen Bio-Technology
Zhejiang Tianyuan Bio-Pharmaceutical
Dalian Yalifeng Bio-Pharmaceutical
Sinopharm


1 Influenza Virus Vaccine (H1N1) Market Overview

  • 1.1 Influenza Virus Vaccine (H1N1) Product Scope
  • 1.2 Influenza Virus Vaccine (H1N1) Segment by Type
    • 1.2.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Intramuscular Vaccine
    • 1.2.3 Nasal Spray Vaccine
  • 1.3 Influenza Virus Vaccine (H1N1) Segment by Application
    • 1.3.1 Global Influenza Virus Vaccine (H1N1) Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 3 To 10 Years Old
    • 1.3.3 10 To 18 Years Old
    • 1.3.4 Above 18 Years Old
    • 1.3.5 Other
  • 1.4 Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Influenza Virus Vaccine (H1N1) Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Influenza Virus Vaccine (H1N1) Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Influenza Virus Vaccine (H1N1) Price Trends (2016-2027)

2 Influenza Virus Vaccine (H1N1) Estimates and Forecasts by Region

  • 2.1 Global Influenza Virus Vaccine (H1N1) Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2016-2021)
  • 2.3 Global Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Influenza Virus Vaccine (H1N1) Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
    • 2.4.2 Europe Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
    • 2.4.3 China Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
    • 2.4.4 Japan Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
    • 2.4.6 India Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)

3 Global Influenza Virus Vaccine (H1N1) Competition Landscape by Players

  • 3.1 Global Top Influenza Virus Vaccine (H1N1) Players by Sales (2016-2021)
  • 3.2 Global Top Influenza Virus Vaccine (H1N1) Players by Revenue (2016-2021)
  • 3.3 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2020)
  • 3.4 Global Influenza Virus Vaccine (H1N1) Average Price by Company (2016-2021)
  • 3.5 Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Influenza Virus Vaccine (H1N1) Market Size by Type

  • 4.1 Global Influenza Virus Vaccine (H1N1) Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Influenza Virus Vaccine (H1N1) Price by Type (2016-2021)
  • 4.2 Global Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Influenza Virus Vaccine (H1N1) Price Forecast by Type (2022-2027)

5 Global Influenza Virus Vaccine (H1N1) Market Size by Application

  • 5.1 Global Influenza Virus Vaccine (H1N1) Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Influenza Virus Vaccine (H1N1) Price by Application (2016-2021)
  • 5.2 Global Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027)

6 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures

  • 6.1 North America Influenza Virus Vaccine (H1N1) Sales by Company
    • 6.1.1 North America Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
    • 6.1.2 North America Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
  • 6.2 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
    • 6.2.1 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
  • 6.3 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
    • 6.3.1 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2022-2027)

7 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures

  • 7.1 Europe Influenza Virus Vaccine (H1N1) Sales by Company
    • 7.1.1 Europe Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
    • 7.1.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
  • 7.2 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
    • 7.2.1 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
    • 7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)

8 China Influenza Virus Vaccine (H1N1) Market Facts & Figures

  • 8.1 China Influenza Virus Vaccine (H1N1) Sales by Company
    • 8.1.1 China Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
    • 8.1.2 China Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
  • 8.2 China Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
    • 8.2.1 China Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
  • 8.3 China Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
    • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Influenza Virus Vaccine (H1N1) Market Facts & Figures

  • 9.1 Japan Influenza Virus Vaccine (H1N1) Sales by Company
    • 9.1.1 Japan Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
    • 9.1.2 Japan Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
  • 9.2 Japan Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
    • 9.2.1 Japan Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Influenza Virus Vaccine (H1N1) Market Facts & Figures

  • 10.1 Southeast Asia Influenza Virus Vaccine (H1N1) Sales by Company
    • 10.1.1 Southeast Asia Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
    • 10.2.1 Southeast Asia Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Influenza Virus Vaccine (H1N1) Market Facts & Figures

  • 11.1 India Influenza Virus Vaccine (H1N1) Sales by Company
    • 11.1.1 India Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
    • 11.1.2 India Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
  • 11.2 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
    • 11.2.1 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
  • 11.3 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
    • 11.3.1 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Influenza Virus Vaccine (H1N1) Business

  • 12.1 CSL
    • 12.1.1 CSL Corporation Information
    • 12.1.2 CSL Business Overview
    • 12.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 CSL Influenza Virus Vaccine (H1N1) Products Offered
    • 12.1.5 CSL Recent Development
  • 12.2 NVS(Novartis)
    • 12.2.1 NVS(Novartis) Corporation Information
    • 12.2.2 NVS(Novartis) Business Overview
    • 12.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Products Offered
    • 12.2.5 NVS(Novartis) Recent Development
  • 12.3 Sanofi Pasteur
    • 12.3.1 Sanofi Pasteur Corporation Information
    • 12.3.2 Sanofi Pasteur Business Overview
    • 12.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Products Offered
    • 12.3.5 Sanofi Pasteur Recent Development
  • 12.4 Medimmune
    • 12.4.1 Medimmune Corporation Information
    • 12.4.2 Medimmune Business Overview
    • 12.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Medimmune Influenza Virus Vaccine (H1N1) Products Offered
    • 12.4.5 Medimmune Recent Development
  • 12.5 GSK
    • 12.5.1 GSK Corporation Information
    • 12.5.2 GSK Business Overview
    • 12.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 GSK Influenza Virus Vaccine (H1N1) Products Offered
    • 12.5.5 GSK Recent Development
  • 12.6 Baxter
    • 12.6.1 Baxter Corporation Information
    • 12.6.2 Baxter Business Overview
    • 12.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Baxter Influenza Virus Vaccine (H1N1) Products Offered
    • 12.6.5 Baxter Recent Development
  • 12.7 Beijing Kexing Bio-Vaccine
    • 12.7.1 Beijing Kexing Bio-Vaccine Corporation Information
    • 12.7.2 Beijing Kexing Bio-Vaccine Business Overview
    • 12.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
    • 12.7.5 Beijing Kexing Bio-Vaccine Recent Development
  • 12.8 Hualan Bio-Vaccine
    • 12.8.1 Hualan Bio-Vaccine Corporation Information
    • 12.8.2 Hualan Bio-Vaccine Business Overview
    • 12.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
    • 12.8.5 Hualan Bio-Vaccine Recent Development
  • 12.9 Changchun Changsheng Bio-Technology
    • 12.9.1 Changchun Changsheng Bio-Technology Corporation Information
    • 12.9.2 Changchun Changsheng Bio-Technology Business Overview
    • 12.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered
    • 12.9.5 Changchun Changsheng Bio-Technology Recent Development
  • 12.10 Beijing Tiantan Bio-Products
    • 12.10.1 Beijing Tiantan Bio-Products Corporation Information
    • 12.10.2 Beijing Tiantan Bio-Products Business Overview
    • 12.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Products Offered
    • 12.10.5 Beijing Tiantan Bio-Products Recent Development
  • 12.11 Jiangsu Yanshen Bio-Technology
    • 12.11.1 Jiangsu Yanshen Bio-Technology Corporation Information
    • 12.11.2 Jiangsu Yanshen Bio-Technology Business Overview
    • 12.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered
    • 12.11.5 Jiangsu Yanshen Bio-Technology Recent Development
  • 12.12 Zhejiang Tianyuan Bio-Pharmaceutical
    • 12.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
    • 12.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
    • 12.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Products Offered
    • 12.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
  • 12.13 Dalian Yalifeng Bio-Pharmaceutical
    • 12.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information
    • 12.13.2 Dalian Yalifeng Bio-Pharmaceutical Business Overview
    • 12.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Products Offered
    • 12.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development
  • 12.14 Sinopharm
    • 12.14.1 Sinopharm Corporation Information
    • 12.14.2 Sinopharm Business Overview
    • 12.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Products Offered
    • 12.14.5 Sinopharm Recent Development

13 Influenza Virus Vaccine (H1N1) Manufacturing Cost Analysis

  • 13.1 Influenza Virus Vaccine (H1N1) Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
  • 13.4 Influenza Virus Vaccine (H1N1) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Influenza Virus Vaccine (H1N1) Distributors List
  • 14.3 Influenza Virus Vaccine (H1N1) Customers

15 Market Dynamics

  • 15.1 Influenza Virus Vaccine (H1N1) Market Trends
  • 15.2 Influenza Virus Vaccine (H1N1) Drivers
  • 15.3 Influenza Virus Vaccine (H1N1) Market Challenges
  • 15.4 Influenza Virus Vaccine (H1N1) Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Influenza Virus Vaccine (H1N1). Industry analysis & Market Report on Influenza Virus Vaccine (H1N1) is a syndicated market report, published as Global Influenza Virus Vaccine (H1N1) Sales Market Report 2021. It is complete Research Study and Industry Analysis of Influenza Virus Vaccine (H1N1) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,000.00
    		$6,000.00
    		$8,000.00
    		3,092.00
    		4,638.00
    		6,184.00
    		3,724.00
    		5,586.00
    		7,448.00
    		610,760.00
    		916,140.00
    		1,221,520.00
    		337,600.00
    		506,400.00
    		675,200.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo